Mixed hyperlipidemia. E78.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM E78.2 became effective on October 1, 2018.
This is the American ICD-10-CM version of E78.2 - other international versions of ICD-10 E78.2 may differ. Applicable To. Broad- or floating-betalipoproteinemia. Combined hyperlipidemia NOS. Elevated cholesterol with elevated triglycerides NEC. Fredrickson's hyperlipoproteinemia, type IIb or III.
Excess of lipids in the blood. ICD-10-CM E78.5 is grouped within Diagnostic Related Group(s) (MS-DRG v 38.0): 642 Inborn and other disorders of metabolism; Convert E78.5 to ICD-9-CM. Code History. 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM) 2017 (effective 10/1/2016): No change; 2018 (effective 10/1/2017): No change
Hyperlipidemia ICD 10 Code Description; E78.0: Pure hypercholesterolemia group A · E78.00: Pure hypercholesterolemia Fredrickson's hyperlipoproteinemia, type Iia Hyperbetalipoproteinemia (Pure) hypercholesterolemia NOS · E78.01: Familial hypercholesterolemia: E78.1: Hyperlipidemia, group B Pure hyperglyceredemia
220.
ICD-10 code E78. 4 for Other hyperlipidemia is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
Encounter for other specified aftercareICD-10 code Z51. 89 for Encounter for other specified aftercare is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
For example, E78. 2 Mixed hyperlipidemia cannot be coded with 5-alpha-reductase deficiency (E29. 1 Testicular hypofunction), but the note for this is not at E78.
Encounter for screening for lipoid disorders Z13. 220 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13. 220 became effective on October 1, 2021.
Hyperlipidemia (high cholesterol) means your blood has too many lipids (fats) in it. These can add up and lead to blockages in your blood vessels. This is why high cholesterol can put you at risk for a stroke or heart attack.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Aftercare visit codes are assigned in situations in which the initial treatment of a disease has been performed but the patient requires continued care during the healing or recovery phase, or for the long-term consequences of the disease.
Encounter for other specified aftercare 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z51. 89 became effective on October 1, 2021. This is the American ICD-10-CM version of Z51.
A disorder of lipoprotein metabolism characterized by high levels of cholesterol and triglycerides in the blood. It is caused by elevation of low density and very low density lipoproteins.
You wouldn't code them together. Cholesterol is a type of lipid. If the provider diagnosed pure hypercholesterolemia, you would code that. It is more specific than hyperlipidemia, unspecified.
In simple meaning Excludes 1, note codes cannot be coded together with that ICD 10 code. Now, coming to Excludes 2 it is totally opposite to Excludes 1. The codes in Excludes 2 can be used together at same time.
E78.2 is a billable diagnosis code used to specify a medical diagnosis of mixed hyperlipidemia. The code E78.2 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
E78.2 is a valid billable ICD-10 diagnosis code for Mixed hyperlipidemia.It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022.. ↓ See below for any exclusions, inclusions or special notations
ICD-10-CM Code for Mixed hyperlipidemia E78.2 ICD-10 code E78.2 for Mixed hyperlipidemia is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
Note. All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Hypertriglyceridemia denotes high (hyper-) blood levels (-emia) of triglycerides, the most abundant fatty molecule in most organisms. Elevated levels of triglycerides are associated with atherosclerosis, even in the absence of hypercholesterolemia (high cholesterol levels), and predispose to cardiovascular disease.
Note. All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Xanthoma tuberosum. Clinical Information. A disorder of lipoprotein metabolism characterized by high levels of cholesterol and triglycerides in the blood. It is caused by elevation of low density and very low density lipoproteins.
Type iib hyperlipoproteinemia is caused by mutation in the receptor-binding domain of apolipoprotein b-100 which is a major component of low-density lipoproteins and very-low-density lipoproteins resulting in reduced clearance of these lipoproteins.
A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma cholesterol and/or triglycerides. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (upstream stimulatory factors) on chromosome 1.
It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as E78.2. A type 1 excludes note is for used for when two conditions cannot occur together , such as a congenital form versus an acquired form of the same condition.
Xanthoma tuberosum. Clinical Information. A disorder of lipoprotein metabolism characterized by high levels of cholesterol and triglycerides in the blood. It is caused by elevation of low density and very low density lipoproteins.
Type iib hyperlipoproteinemia is caused by mutation in the receptor-binding domain of apolipoprotein b-100 which is a major component of low-density lipoproteins and very-low-density lipoproteins resulting in reduced clearance of these lipoproteins.
A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma cholesterol and/or triglycerides. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (upstream stimulatory factors) on chromosome 1.
It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as E78.2. A type 1 excludes note is for used for when two conditions cannot occur together , such as a congenital form versus an acquired form of the same condition.